ONXX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Onyx Pharmaceuticals, Inc.'s special charges for the three months ended in Jun. 2013 was $0.0 Mil. Its special charges for the trailing twelve months (TTM) ended in Jun. 2013 was $5.9 Mil.
It is nonrecurring losses or expenses resulting from transactions or events which, in the view of management, are not representative of normal business activities of the period and which affect comparability of earnings.
Onyx Pharmaceuticals, Inc. SpecialCharges for the trailing twelve months (TTM) ended in Jun. 2013 was 0 (Sep. 2012 ) + 2.937 (Dec. 2012 ) + 2.93 (Mar. 2013 ) + 0 (Jun. 2013 ) = $5.9 Mil.
Onyx Pharmaceuticals, Inc. Annual Data
Onyx Pharmaceuticals, Inc. Quarterly Data